Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Other Working Capital Changes: 2016-2024

Historic Other Working Capital Changes for Krystal Biotech (KRYS) over the last 9 years, with Dec 2024 value amounting to $8.9 million.

  • Krystal Biotech's Other Working Capital Changes rose 358.40% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.2 million, marking a year-over-year increase of 259.48%. This contributed to the annual value of $8.9 million for FY2024, which is 452.67% up from last year.
  • Krystal Biotech's Other Working Capital Changes amounted to $8.9 million in FY2024, which was up 452.67% from $1.6 million recorded in FY2023.
  • Krystal Biotech's 5-year Other Working Capital Changes high stood at $8.9 million for FY2024, and its period low was $615,000 during FY2022.
  • Its 3-year average for Other Working Capital Changes is $3.7 million, with a median of $1.6 million in 2023.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first crashed by 64.05% in 2021, then soared by 452.67% in 2024.
  • Yearly analysis of 5 years shows Krystal Biotech's Other Working Capital Changes stood at $1.9 million in 2020, then plummeted by 64.05% to $691,000 in 2021, then fell by 11.00% to $615,000 in 2022, then soared by 162.11% to $1.6 million in 2023, then soared by 452.67% to $8.9 million in 2024.